Pfizer, BioNTech Vaccine Trial Remains on Track, CEO Says

Bookmark
(Bloomberg) -- Side effects that have emerged in a large late-stage trial of a Covid-19 vaccine candidate from Pfizer Inc. and BioNTech SE are in line with those seen in smaller early studies, a po...